Sign in or create an account to add this stock to your watchlist.
About Pharming Group (OTCMKTS:PHGUF)
Pharming Group N.V., a specialty pharmaceutical company, develops and produces human therapeutic proteins for the treatment of rare diseases and unmet medical needs. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of angioedema attacks in patients with acute hereditary angioedema (HAE) in Europe, the United States, Israel, European Union countries, Norway, Iceland, and Liechtenstein. It also engages in the development of recombinant human C1 inhibitor for treating HAE attacks; and recombinant human factor VIII (rhFVIII), a natural human blood clotting factor for treating haemophilia A. The company has a strategic collaboration with Shanghai Institute of Pharmaceutical Industry for the development, manufacture, and commercialization of new products based on the Pharming technology platform; and a partnership agreement with the China State Institute of Pharmaceutical Industry for the development of rhFVIII for the treatment of Haemophilia A. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
Industry, Sector and Symbol
Industry Tobacco products
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PHGUF
CUSIPN/A
Phone31-71-524-7400
Debt
Debt-to-Equity Ratio3.14
Current Ratio1.51
Quick Ratio1.19
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$101.29 million
Price / Sales8.86
Cash FlowN/A
Price / CashN/A
Book Value$0.04 per share
Price / Book38.75
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-90,370,000.00
Net Margins-69.48%
Return on Equity-259.69%
Return on Assets-33.75%
Miscellaneous
Employees94
Outstanding Shares579,020,000
Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions
What is Pharming Group's stock symbol?
Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."
How were Pharming Group's earnings last quarter?
Pharming Group (OTCMKTS:PHGUF) released its earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Pharming Group had a negative return on equity of 259.69% and a negative net margin of 69.48%. View Pharming Group's Earnings History.
When is Pharming Group's next earnings date?
Who are some of Pharming Group's key competitors?
Who are Pharming Group's key executives?
Pharming Group's management team includes the folowing people:
- Dr. Sijmen de Vries M.D., MBA, Chairman of Management Board and Chief Exec. Officer (Age 59)
- Mr. Robin Wright BA (Oxon), FCA., Chief Financial Officer and Member of Management Board (Age 54)
- Dr. Bruno M. L. Giannetti M.D., Ph.D., Chief Operations Officer and Member of Management Board (Age 66)
- Dr. Pericles Calias Ph.D., Chief Scientific Officer
- Mr. Paul Th. Janssen MA MBA MSc, VP of Marketing & Sales (Age 49)
Has Pharming Group been receiving favorable news coverage?
News coverage about PHGUF stock has been trending somewhat negative on Tuesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pharming Group earned a media sentiment score of -0.02 on Accern's scale. They also gave news stories about the biotechnology company an impact score of 47.23 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Pharming Group?
Shares of PHGUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pharming Group's stock price today?
One share of PHGUF stock can currently be purchased for approximately $1.55.
How big of a company is Pharming Group?
Pharming Group has a market capitalization of $874.31 million and generates $101.29 million in revenue each year. Pharming Group employs 94 workers across the globe.
How can I contact Pharming Group?
Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company can be reached via phone at 31-71-524-7400 or via email at [email protected]
MarketBeat Community Rating for Pharming Group (PHGUF)
MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote "Outperform" if you believe PHGUF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHGUF will underperform the S&P 500 over the long term. You may vote once every thirty days.
Pharming Group (OTCMKTS:PHGUF) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Pharming Group in the last 12 months. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
Pharming Group (OTCMKTS:PHGUF) Consensus Price Target History
Pharming Group (OTCMKTS:PHGUF) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 3/7/2018 | Roth Capital | Reiterated Rating | Buy | |  |
| 10/26/2017 | HC Wainwright | Reiterated Rating | Buy | | |
(Data available from 5/22/2016 forward)
Pharming Group (OTCMKTS:PHGUF) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Pharming Group (OTCMKTS PHGUF) Insider Trading and Institutional Ownership History
Pharming Group (OTCMKTS PHGUF) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Pharming Group (OTCMKTS PHGUF) News Headlines
| Source: |
|
Pharming Group (OTCMKTS:PHGUF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Pharming Group (OTCMKTS PHGUF) Stock Chart for Tuesday, May, 22, 2018
Loading chart…
